Your browser doesn't support javascript.
loading
Does the Act on the Safety of Regenerative Medicine in Japan ensure "safety"?: Implications of low adverse event reporting.
Ikka, Tsunakuni; Hatta, Taichi; Saito, Yoko; Fujita, Misao.
Affiliation
  • Ikka T; Division of Bioethics & Healthcare Law, Institute for Cancer Control, National Cancer Center Japan, Chuo-ku, Tokyo 104-0045, Japan; Division of Bioethics, Center for Research Administration and Support, National Cancer Center Japan, Chuo-ku, Tokyo 104-0045, Japan. Electronic address: tikka@ncc.g
  • Hatta T; Graduate School of Public Health, Shizuoka Graduate University of Public Health, Aoi-ku, Shizuoka 420-0881, Japan. Electronic address: thatta@s-sph.ac.jp.
  • Saito Y; Division of Bioethics, Center for Research Administration and Support, National Cancer Center Japan, Chuo-ku, Tokyo 104-0045, Japan.
  • Fujita M; Uehiro Research Division for iPS Cell Ethics, Center for iPS Cell Research and Application (CiRA), Kyoto University, Sakyo-ku, Kyoto 606-8507, Japan; Institute for the Advanced Study of Human Biology (WPI-ASHBi), KUIAS, Kyoto University, Sakyo-ku, Kyoto 606-8501, Japan.
Stem Cell Reports ; 18(12): 2297-2299, 2023 12 12.
Article in En | MEDLINE | ID: mdl-37977143
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Regenerative Medicine Country/Region as subject: Asia Language: En Journal: Stem Cell Reports Year: 2023 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Regenerative Medicine Country/Region as subject: Asia Language: En Journal: Stem Cell Reports Year: 2023 Document type: Article Country of publication: